Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.50
Delayed Data
As of Feb 22
 -0.10 / -3.85%
Today’s Change
1.65
Today|||52-Week Range
4.90
0.00%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.60
Today’s open2.53
Day’s range2.48 - 2.60
Volume86,023
Average volume (3 months)107,353
Market cap$48.4M
Dividend yield--
Data as of 3:59pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+20.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZSANZosano Pharma Corp-0.26-9.06%
EBIOEleven Biotherapeuti...-0.02-0.98%
BLPHBellerophon Therapeu...-0.19-12.75%
AMPEAmpio Pharmaceutical...-0.05-5.88%
Data as of 4:02pm ET, 02/22/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Vice President-
Operations
Clayton D. Edwards
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs